RE:RE:RE:RE:in the NRcharm7 wrote: Hey Staghorn69 how much do you think Boehringer Ingelheim would invest if the 4050 and Nintedanib are a sucessful combination?
Well that's the million dollar question Charm. Who knows. I do know that a standalone treatment will be worth FAR more than a complimentary one, and how much they or anyone would be willing to spend on the complimentary treatment is beyond me. If - IF - 4050 and nintedanib become THE IPF treatment due to the synergy, that makes 4050 worth a lot. If 4050 beats them all though in the trials, I'd say it's worth LOTS. Billions.